Dipeptidyl peptidase-4 inhibitor impacts the expression of Bcl-2 and Bax through γ amino acid bwtyric acid in pancreas islets
Ying Dong, Qiang Li, Jingfang Chen, Ping Wang
Abstract
Ying Dong, Qiang Li, Jingfang Chen, Ping Wang
Abstract
Objective To explore the effects of dipeptidyl peptidase(DPP-4)inhibitor on proteins expression of Bcl-2 and Bax of islet β-cells through increasing the expression of islet γ amino acid butyric acid(GABA). Methods A total of 50 rats of clean grade were studied. Among them, ten rats were randomly selected as normal controls, the remaining forty rats were fed with high-fat diet and then intraperitoneal injection with streptozotocin, the diabetic rats models were then established. Rats were randomly divided into three groups: i.e. diabetic control group, DPP-4 inhibitor group, and antagonist group(DPP-4 inhibitor and GABA receptor antagonist). Six weeks later, blood glucose, serum insulin, glucagon, and the proteins expression of GABA, Bcl-2, and Bax of islet β-cells were measured. Results (1)Compared with diabetic control group, serum insulin was increased(P<0.05), blood glucose and serum glucagon were decreased in DPP-4 inhibitor group(P<0.05). (2)Compared with DPP-4 inhibitor group, serum insulin was decreased(P<0.05), blood glucose and serum glucagon were increased(P<0.05)in antagonist group.(3)Compared with diabetic control group, the expression of GABA was increased(P<0.05), the expression of Bcl-2 protein was increased(P<0.05)in pancreatic β-cells in DPP-4 inhibitor group.(4)Compared with diabetic control group, the expression of GABA in pancreatic β-cells was increased in antagonist group(P<0.05). Compared with DPP-4 inhibitor group, the expression of Bax protein in pancreatic β-cells was increased in antagonist group(P<0.05), while the expression of Bcl-2 protein was decreased(P<0.05). Conclusions DPP-4 inhibitor could increase the secretion of insulin, decrease the secretion of glucagon, up-regulate expression of anti-apoptosis protein Bcl-2, and down-regulate expression of apoptosis protein Bax in pancreatic β-cells through increasing the expression of GABA, inhibiting pancreatic β-cells apoptosis and protecting the damaged β-cells in type 2 diabetic rats. (Chin J Endocrinol Metab, 2016, 32: 227-231) Key words: Dipeptidyl peptidase-4 inhibitor; γ amino acid butyric acid; Bcl-2 protein; Bax protein; Islet β -cell apoptosis
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effects of dipeptidyl peptidase(DPP-4)inhibitor on proteins expression of Bcl-2 and Bax of islet β-cells through increasing the expression of islet γ amino acid butyric acid(GABA). Methods A total of 50 rats of clean grade were studied. Among them, ten rats were randomly selected as normal controls, the remaining forty rats were fed with high-fat diet and then intraperitoneal injection with streptozotocin, the diabetic rats models were then established. Rats were randomly divided into three groups: i.e. diabetic control group, DPP-4 inhibitor group, and antagonist group(DPP-4 inhibitor and GABA receptor antagonist). Six weeks later, blood glucose, serum insulin, glucagon, and the proteins expression of GABA, Bcl-2, and Bax of islet β-cells were measured. Results (1)Compared with diabetic control group, serum insulin was increased(P<0.05), blood glucose and serum glucagon were decreased in DPP-4 inhibitor group(P<0.05). (2)Compared with DPP-4 inhibitor group, serum insulin was decreased(P<0.05), blood glucose and serum glucagon were increased(P<0.05)in antagonist group.(3)Compared with diabetic control group, the expression of GABA was increased(P<0.05), the expression of Bcl-2 protein was increased(P<0.05)in pancreatic β-cells in DPP-4 inhibitor group.(4)Compared with diabetic control group, the expression of GABA in pancreatic β-cells was increased in antagonist group(P<0.05). Compared with DPP-4 inhibitor group, the expression of Bax protein in pancreatic β-cells was increased in antagonist group(P<0.05), while the expression of Bcl-2 protein was decreased(P<0.05). Conclusions DPP-4 inhibitor could increase the secretion of insulin, decrease the secretion of glucagon, up-regulate expression of anti-apoptosis protein Bcl-2, and down-regulate expression of apoptosis protein Bax in pancreatic β-cells through increasing the expression of GABA, inhibiting pancreatic β-cells apoptosis and protecting the damaged β-cells in type 2 diabetic rats. (Chin J Endocrinol Metab, 2016, 32: 227-231) Key words: Dipeptidyl peptidase-4 inhibitor; γ amino acid butyric acid; Bcl-2 protein; Bax protein; Islet β -cell apoptosis
Key concepts: Internal medicine, Endocrinology, Antagonist, Pancreas, Streptozotocin, Intraperitoneal injection, Glucagon, Islet